These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16923452)

  • 1. Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia.
    Devaraj S; Autret B; Jialal I
    Am J Cardiol; 2006 Sep; 98(5):641-3. PubMed ID: 16923452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH; Donovan JM; Misir S; Jones MR
    Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H; Rhyne J; Abby S; Lai YL; Jones M
    Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia.
    Rosenson RS
    Atherosclerosis; 2006 Apr; 185(2):327-30. PubMed ID: 16009365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
    Insull W; Toth P; Mullican W; Hunninghake D; Burke S; Donovan JM; Davidson MH
    Mayo Clin Proc; 2001 Oct; 76(10):971-82. PubMed ID: 11605698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
    Knopp RH; Tsunehara C; Retzlaff BM; Fish B; Nguyen H; Anderson S; Nguyen T
    Metabolism; 2006 Dec; 55(12):1697-703. PubMed ID: 17142146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia.
    McKenney J; Jones M; Abby S
    Curr Med Res Opin; 2005 Sep; 21(9):1403-12. PubMed ID: 16197659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
    Davidson MH; Dillon MA; Gordon B; Jones P; Samuels J; Weiss S; Isaacsohn J; Toth P; Burke SK
    Arch Intern Med; 1999 Sep; 159(16):1893-900. PubMed ID: 10493319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colesevelam hydrochloride: a novel bile acid-binding resin.
    Aldridge MA; Ito MK
    Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colesevelam: a review of its use in hypercholesterolemia.
    Robinson DM; Keating GM
    Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE
    Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
    Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
    Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
    Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.
    Linnebur SA; Capell WH; Saseen JJ; Wolfe P; Eckel RH
    J Clin Lipidol; 2007 Dec; 1(6):626-33. PubMed ID: 21291705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
    Perry CM
    Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
    Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR
    Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.